Nordic Pharma Lab ApS: Financial statements 2018
CVR: 39161672
Source: annual report 2018, Danish Business Authority
10/12/2017 – 31/12/2018
Nordic Pharma Lab ApS (CVR 39161672) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -11,340 and a net result of DKK -11,340. Equity in the 2018 report amounted to DKK 88,660. The solvency ratio was 92.2%.
- Gross Profit
- DKK -11,340
- Profit/Loss
- DKK -11,340
- Equity
- DKK 88,660
- Total Assets
- DKK 96,160
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
On January 11, 2018, the company changed its name from ApS STM nr. 6145 to Nordic Pharma Lab ApS.
About Nordic Pharma Lab ApS
Nordic Pharma Lab ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS STM nr. 6145. The management consists of Torsten Bjørn. The company's owners include TT 1919 ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,093 and a net result of DKK -110,916 compared with DKK -30,573 the year before. Equity in the 2025 report amounted to DKK -429,426.